169 related articles for article (PubMed ID: 2472644)
1. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings.
Schiebler ML; Tomaszewski JE; Bezzi M; Pollack HM; Kressel HY; Cohen EK; Altman HG; Gefter WB; Wein AJ; Axel L
Radiology; 1989 Jul; 172(1):131-7. PubMed ID: 2472644
[TBL] [Abstract][Full Text] [Related]
2. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.
Kahn T; Bürrig K; Schmitz-Dräger B; Lewin JS; Fürst G; Mödder U
Radiology; 1989 Dec; 173(3):847-51. PubMed ID: 2479050
[TBL] [Abstract][Full Text] [Related]
3. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.
Ling D; Lee JK; Heiken JP; Balfe DM; Glazer HS; McClennan BL
Radiology; 1986 Jan; 158(1):103-7. PubMed ID: 2416005
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance tomography of prostatic cancer. A histopathologic correlation].
Kahn T; Bürrig KF; Schmitz-Dräger B; Fürst G; Stork W; Mödder U
Radiologe; 1989 Mar; 29(3):144-9. PubMed ID: 2469100
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance of the prostate: critical evaluation of diagnostic possibilities].
Beomonte Zobel B; Testa A; Tella S; Masciocchi C; Gallucci M; Laconi MM; Di Nicola G; Passariello R
Radiol Med; 1989 Sep; 78(3):216-24. PubMed ID: 2477877
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome.
deSouza NM; Flynn RJ; Coutts GA; Gilderdale DJ; Hall AS; Puni R; Chui M; Harris DN; Kiely EA
AJR Am J Roentgenol; 1995 Jun; 164(6):1429-34. PubMed ID: 7538727
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
8. Prostatic disorders: MR imaging at 1.5 T.
Phillips ME; Kressel HY; Spritzer CE; Arger PH; Wein AJ; Marinelli D; Axel L; Gefter WB; Pollack HM
Radiology; 1987 Aug; 164(2):386-92. PubMed ID: 2440074
[TBL] [Abstract][Full Text] [Related]
9. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation.
Carrol CL; Sommer FG; McNeal JE; Stamey TA
Radiology; 1987 May; 163(2):521-5. PubMed ID: 2436253
[TBL] [Abstract][Full Text] [Related]
10. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
Gualdi GF; Polettini E; Casciani E
Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
[TBL] [Abstract][Full Text] [Related]
11. Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.
Kitzing YX; Prando A; Varol C; Karczmar GS; Maclean F; Oto A
Radiographics; 2016; 36(1):162-75. PubMed ID: 26587887
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination.
Quint LE; Van Erp JS; Bland PH; Del Buono EA; Mandell SH; Grossman HB; Gikas PW
Radiology; 1991 Jun; 179(3):837-42. PubMed ID: 2028002
[TBL] [Abstract][Full Text] [Related]
13. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia: value of MR imaging for determining histologic type.
Ishida J; Sugimura K; Okizuka H; Kaji Y; Moriyama M; Nagaoka S; Mizutani M; Ishida T
Radiology; 1994 Feb; 190(2):329-31. PubMed ID: 7506836
[TBL] [Abstract][Full Text] [Related]
15. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
16. MR characteristics of prostatic carcinoma and benign prostatic hyperplasia at 1.5 T.
Griebel J; Hess CF; Schmiedl U; Koelbel G
J Comput Assist Tomogr; 1988; 12(6):988-94. PubMed ID: 2460511
[TBL] [Abstract][Full Text] [Related]
17. Coagulative interstitial laser-induced thermotherapy of benign prostatic hyperplasia: online imaging with a T2-weighted fast spin-echo MR sequence--experience in six patients.
Mueller-Lisse UG; Thoma M; Faber S; Heuck AF; Muschter R; Schneede P; Weninger E; Hofstetter AG; Reiser MF
Radiology; 1999 Feb; 210(2):373-9. PubMed ID: 10207417
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology.
Turnbull LW; Buckley DL; Turnbull LS; Liney GP; Knowles AJ
J Magn Reson Imaging; 1999 Feb; 9(2):311-6. PubMed ID: 10077030
[TBL] [Abstract][Full Text] [Related]
19. MR imaging characteristics of noncancerous lesions of the prostate.
Lovett K; Rifkin MD; McCue PA; Choi H
J Magn Reson Imaging; 1992; 2(1):35-9. PubMed ID: 1377976
[TBL] [Abstract][Full Text] [Related]
20. Morphologic basis of MR imaging of benign prostatic hyperplasia.
Hruban RH; Zerhouni EA; Dagher AP; Pessar ML; Hutchins GM
J Comput Assist Tomogr; 1987; 11(6):1035-41. PubMed ID: 2445800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
